|
||
Original Article |
Correspondence to: Carl H. June, Department of Molecular and Cellular Engineering, University of Pennsylvania, BRB II/III, Rm. 554, 421 Curie Blvd., Philadelphia, PA 19104-6160. Tel:215-573-5745 Fax:215-573-8590 E-mail:cjune{at}mail.med.upenn.edu.
CD4 T cells activated in vitro by anti-CD3/28coated beads are resistant to infection by CC chemokine receptor 5 (CCR5)-dependent HIV-1 isolates. In vivo, antigen-presenting cells (APCs) activate CD4 T cells in part by signaling through the T cell receptor and CD28, yet cells stimulated in this manner are susceptible to HIV-1 infection. We show that cytotoxic T lymphocyte antigen 4 (CTLA-4) engagement counteracts the CD28 antiviral effects, and that the ratio of CTLA-4 to CD28 engagement determines the susceptibility of HIV-1 infection. Furthermore, unopposed CTLA-4 signaling provided by CD28 blockade promotes vigorous HIV-1 replication, despite minimal T cell proliferation. Finally, CTLA-4 antibodies decrease the susceptibility of antigen-activated CD4 T cells to HIV, suggesting a potential approach to prevent or limit viral spread in HIV-1infected individuals.
Key Words: HIV, costimulation, T cells, chemokine receptors, chemokines
This article has been cited by other articles:
| TABLE OF CONTENTS |
|